https://it.marketscreener.com/quotazioni/azione/ALZAMEND-NEURO-INC-123731313/attualita/Alzamend-Neuro-riceve-dalla-FDA-la-notifica-Study-May-Proceed-per-l-avvio-di-uno-studio-clinico-di-45402609/?utm_source=telegram&utm_medium=social&utm_campaign=share